We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
+4.66%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.94B
AUM Growth
+$1.21B
(+21%)
Cap. Flow
+$1.03B
Cap. Flow
% of AUM
14.89%
Top 10 Holdings %
Top 10 Hldgs %
53.97%
Holding
274
New
81
Increased
95
Reduced
45
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$73.4M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$72M |
| 3 |
Johnson & Johnson
JNJ
|
+$64.2M |
| 4 |
Colgate-Palmolive
CL
|
+$62.8M |
| 5 |
Dentsply Sirona
XRAY
|
+$52.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pacira BioSciences
PCRX
|
+$73.1M |
| 2 |
Freshpet
FRPT
|
+$58.3M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$48M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$43.7M |
| 5 |
KYNB
Kyntra Bio
KYNB
|
+$32.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.57% |
| 2 | Consumer Staples | 5.26% |
| 3 | Consumer Discretionary | 4.88% |
| 4 | Technology | 4.62% |
| 5 | Communication Services | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Alibaba
BABA
$304B
| $15.3M | 0.22% |
150,000
-206,000
| -58% | -$20.6M |
|
77
Kura Oncology
KURA
$824M
| $15.1M | 0.22% |
1,236,000
+164,000
| +15% | +$2.05M |
|
|
ATVI
78
DELISTED
Activision Blizzard
ATVI
| $14.4M | 0.21% |
168,000
-88,000
| -34% | -$6.83M |
|
79
Simply Good Foods
SMPL
$988M
| $13.5M | 0.19% |
+339,982
| New | +$12.6M |
|
|
TGNA
80
DELISTED
TEGNA Inc
TGNA
| $12.8M | 0.18% |
756,000
+184,000
| +32% | +$3.44M |
|
81
McDonald's
MCD
$196B
| $12.6M | 0.18% |
+45,000
| New | +$12.1M |
|
|
SPPI
82
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $12.5M | 0.18% |
16,700,000
-300,000
| -2% | -$219K |
|
83
O'Reilly Automotive
ORLY
$76.2B
| $12.5M | 0.18% |
220,500
-49,500
| -18% | -$2.71M |
|
84
M&T Bank
MTB
$36.1B
| $12M | 0.17% |
+100,000
| New | +$14.5M |
|
85
Wynn Resorts
WYNN
$10.5B
| $11.7M | 0.17% |
104,865
+12,865
| +14% | +$1.35M |
|
86
CVS Health
CVS
$123B
| $11.6M | 0.17% |
156,000
-320,000
| -67% | -$26.8M |
|
87
JPMorgan Chase
JPM
$947B
| $10.9M | 0.16% |
+84,000
| New | +$11.5M |
|
88
FIVE9
FIVN
$2.17B
| $10.7M | 0.15% |
+148,000
| New | +$10.6M |
|
89
ImmunityBio
IBRX
$7.76B
| $10.5M | 0.15% |
+5,795,927
| New | +$18M |
|
|
PRVB
90
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $9.64M | 0.14% |
+400,000
| New | +$5.02M |
|
|
FORG
91
DELISTED
ForgeRock, Inc.
FORG
| $9.39M | 0.14% |
456,000
+78,000
| +21% | +$1.58M |
|
92
Sol-Gel Technologies
SLGL
$284M
| $9.34M | 0.13% |
+240,800
| New | +$10.7M |
|
93
SentinelOne
S
$7.12B
| $8.77M | 0.13% |
536,000
+64,000
| +14% | +$967K |
|
|
SPRB
94
Spruce Biosciences
SPRB
$128M
| $8.68M | 0.13% |
+52,373
| New | +$9.73M |
|
95
TSMC
TSM
$2.17T
| $8.56M | 0.12% |
+92,000
| New | +$8.26M |
|
|
VMW
96
DELISTED
VMware, Inc
VMW
| $8.49M | 0.12% |
+68,000
| New | +$8.17M |
|
|
NARI
97
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $8.4M | 0.12% |
+136,000
| New | +$8.16M |
|
98
NVIDIA
NVDA
$5.3T
| $8.33M | 0.12% |
300,000
-420,000
| -58% | -$9.09M |
|
99
Avalo Therapeutics
AVTX
$989M
| $7.73M | 0.11% |
18,396
+1,877
| +11% | +$1.48M |
|
100
Insulet
PODD
$9.65B
| $7.66M | 0.11% |
24,000
-11,000
| -31% | -$3.26M |
|
Similar funds
CRC
RMDI
F
EW
O
DSC
ACM
PI
Armistice Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Armistice Capital held 274 positions worth $6.94B, up 21% from $5.73B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Armistice Capital deployed $1.03B of net new capital in Q1 2023, opening 81 new positions and adding to 95 existing holdings. Its largest new stake was DICE Therapeutics, Inc. Common Stock: 1,376,000 shares worth $39.4M.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 46% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
On the sell side, the largest reduction was Freshpet, an estimated $58.3M trimmed.
- Armistice Capital's largest Q1 2023 buy was DICE Therapeutics, Inc. Common Stock: 1,376,000 shares worth $39.4M.
- Armistice Capital added most to UnitedHealth in Q1 2023, an estimated $73.4M increase.
- Armistice Capital's biggest Q1 2023 reduction was Freshpet, cutting an estimated $58.3M.
- Armistice Capital fully exited Pacira BioSciences in Q1 2023, selling an estimated $73.1M.
- Armistice Capital's ten largest holdings make up 54% of its $6.94B portfolio in Q1 2023.
- Armistice Capital opened 81 new positions and closed 48 in Q1 2023.
- Armistice Capital's portfolio value rose 21% quarter-over-quarter to $6.94B.
Based on Armistice Capital's 13F filing for Q1 2023, filed 15 May 2023.